Healthcare provider profile · identity verified

Ryan D. Lowers, M.D.

Family Practice · VIENNA, WV · NPI 1770791733

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	846	171
Atorvastatin Calcium	Atorvastatin Calcium	714	197
Pantoprazole Sodium	Pantoprazole Sodium	631	178
Losartan Potassium	Losartan Potassium	515	131
Sertraline Hcl	Sertraline Hcl	385	89
Amlodipine Besylate	Amlodipine Besylate	374	102
Lisinopril	Lisinopril	373	107
Hydrochlorothiazide	Hydrochlorothiazide	334	102
Metformin Hcl	Metformin Hcl	322	86
Metoprolol Succinate	Metoprolol Succinate	304	78
Furosemide	Furosemide	286	79
Allopurinol	Allopurinol	228	41
Omeprazole	Omeprazole	224	62
Gabapentin	Gabapentin	195	56
Simvastatin	Simvastatin	193	51
Alprazolam	Alprazolam	192	45
Potassium Chloride	Potassium Chloride	190	43
Fluticasone Propionate	Fluticasone Propionate	186	73
Rosuvastatin Calcium	Rosuvastatin Calcium	180	37
Alendronate Sodium	Alendronate Sodium	175	53
Metoprolol Tartrate	Metoprolol Tartrate	161	45
Albuterol Sulfate Hfa	Albuterol Sulfate	157	56
Buspirone Hcl	Buspirone Hcl	156	37
Tamsulosin Hcl	Tamsulosin Hcl	148	41
Mounjaro	Tirzepatide	145	31
Glimepiride	Glimepiride	140	40
Montelukast Sodium	Montelukast Sodium	137	37
Trazodone Hcl	Trazodone Hcl	137	31
Ozempic	Semaglutide	129	21
Pravastatin Sodium	Pravastatin Sodium	122	35
Duloxetine Hcl	Duloxetine Hcl	115	22
Pregabalin	Pregabalin	115	27
Tizanidine Hcl	Tizanidine Hcl	113	37
Clopidogrel	Clopidogrel Bisulfate	105	32
Ezetimibe	Ezetimibe	105	27
Memantine Hcl	Memantine Hcl	104	12
Donepezil Hcl	Donepezil Hcl	103	13
Carvedilol	Carvedilol	101	20
Metformin Hcl Er	Metformin Hcl	95	26
Jardiance	Empagliflozin	94	21
Naproxen	Naproxen	89	37
Eliquis	Apixaban	86	23
Fluoxetine Hcl	Fluoxetine Hcl	85	21
Venlafaxine Hcl Er	Venlafaxine Hcl	84	19
Cephalexin	Cephalexin	82	55
Meloxicam	Meloxicam	81	28
Lorazepam	Lorazepam	79	13
Synthroid	Levothyroxine Sodium	78	16
Tramadol Hcl	Tramadol Hcl	76	12
Mirtazapine	Mirtazapine	74	22
Hydralazine Hcl	Hydralazine Hcl	70	20
Azithromycin	Azithromycin	67	56
Atenolol	Atenolol	64	19
Prednisone	Prednisone	59	24
Zolpidem Tartrate	Zolpidem Tartrate	58	suppressed
Diclofenac Sodium	Diclofenac Sodium	56	14
Irbesartan	Irbesartan	54	suppressed
Celecoxib	Celecoxib	52	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	15
Escitalopram Oxalate	Escitalopram Oxalate	51	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	suppressed
Lovastatin	Lovastatin	47	suppressed
Valacyclovir	Valacyclovir Hcl	47	16
Esomeprazole Magnesium	Esomeprazole Magnesium	46	11
Warfarin Sodium	Warfarin Sodium	46	suppressed
Januvia	Sitagliptin Phosphate	45	13
Citalopram Hbr	Citalopram Hydrobromide	44	13
Finasteride	Finasteride	44	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	44	28
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	43	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	suppressed
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Amoxicillin	Amoxicillin	38	34
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	12
Spironolactone	Spironolactone	38	suppressed
Trulicity	Dulaglutide	37	suppressed
Valsartan	Valsartan	37	suppressed
Famotidine	Famotidine	34	14
Ventolin Hfa	Albuterol Sulfate	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	11
Pioglitazone Hcl	Pioglitazone Hcl	33	12
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Meclizine Hcl	Meclizine Hcl	32	13
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	18
Klor-Con M20	Potassium Chloride	30	suppressed
Nitroglycerin	Nitroglycerin	30	26
Temazepam	Temazepam	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Baclofen	Baclofen	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	28
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Glipizide	Glipizide	28	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Sucralfate	Sucralfate	25	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Fluconazole	Fluconazole	23	17
Ibuprofen	Ibuprofen	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Levemir Flexpen	Insulin Detemir	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	18
Levofloxacin	Levofloxacin	21	19
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Nystatin	Nystatin	19	12
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Acyclovir	Acyclovir	18	suppressed
Ramipril	Ramipril	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Ondansetron Odt	Ondansetron	16	11
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Diazepam	Diazepam	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Digoxin	Digoxin	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Invokana	Canagliflozin	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Mupirocin	Mupirocin	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Plavix	Clopidogrel Bisulfate	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error